Format

Send to

Choose Destination
J Med Genet. 2016 Jul;53(7):472-80. doi: 10.1136/jmedgenet-2015-103740. Epub 2016 Mar 18.

Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations.

Author information

1
Department of Women's Cancer, EGA Institute for Women's Health, University College London, London, UK Department of Gynaecological Oncology, Bartshealth NHS Trust, Royal London Hospital, London, UK Barts Cancer Institute, Queen Mary University of London, London, UK.
2
Department of Women's Cancer, EGA Institute for Women's Health, University College London, London, UK.
3
Behavioural Sciences Unit, Department of Epidemiology and Public Health, University College London, London, UK.
4
Mt Sinai University, New York, USA.
5
Department of Clinical Genetics, North East Thames Regional Genetics Unit, Great Ormond Street Hospital, London, UK.
6
Department of Clinical Genetics, North West Thames Regional Genetics Unit, Northwick Park Hospital, London, UK.
7
West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK.
8
Depatment of Clinical Genetics, West Midlands Regional Genetics, Birmingham Women's NHS Foundation Trust, Birmingham, UK.
9
London Research Institute, Cancer Research UK.
10
South West Thames Molecular Genetics Diagnostic Laboratory, St George's Hospital, London, UK.
11
Department of Clinical Genetics, Guy's Hospital, London, UK.
12
Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
13
Department of Health Economics, London School of Economics, London, UK.
14
Department of Gynaecology, Shaare Zedek Medical Centre, Jerusalem, Israel.
15
Department of Women's Cancer, EGA Institute for Women's Health, University College London, London, UK University of New South Wales, Sydney, Australia.

Abstract

BACKGROUND:

Newer approaches to genetic counselling are required for population-based testing. We compare traditional face-to-face genetic counselling with a DVD-assisted approach for population-based BRCA1/2 testing.

METHODS:

A cluster-randomised non-inferiority trial in the London Ashkenazi Jewish population.

INCLUSION CRITERIA:

Ashkenazi Jewish men/women >18 years; exclusion criteria: (a) known BRCA1/2 mutation, (b) previous BRCA1/2 testing and (c) first-degree relative of BRCA1/2 carrier. Ashkenazi Jewish men/women underwent pre-test genetic counselling prior to BRCA1/2 testing in the Genetic Cancer Prediction through Population Screening trial (ISRCTN73338115). Genetic counselling clinics (clusters) were randomised to traditional counselling (TC) and DVD-based counselling (DVD-C) approaches. DVD-C involved a DVD presentation followed by shorter face-to-face genetic counselling. Outcome measures included genetic testing uptake, cancer risk perception, increase in knowledge, counselling time and satisfaction (Genetic Counselling Satisfaction Scale). Random-effects models adjusted for covariates compared outcomes between TC and DVD-C groups. One-sided 97.5% CI was used to determine non-inferiority.

SECONDARY OUTCOMES:

relevance, satisfaction, adequacy, emotional impact and improved understanding with the DVD; cost-minimisation analysis for TC and DVD-C approaches.

RESULTS:

936 individuals (clusters=256, mean-size=3.6) were randomised to TC (n=527, clusters=134) and DVD-C (n=409, clusters=122) approaches. Groups were similar at baseline, mean age=53.9 (SD=15) years, women=66.8%, men=33.2%. DVD-C was non-inferior to TC for increase in knowledge (d=-0.07; lower 97.5% CI=-0.41), counselling satisfaction (d=-0.38, 97.5% CI=1.2) and risk perception (d=0.08; upper 97.5% CI=3.1). Group differences and CIs did not cross non-inferiority margins. DVD-C was equivalent to TC for uptake of genetic testing (d=-3%; lower/upper 97.5% CI -7.9%/1.7%) and superior for counselling time (20.4 (CI 18.7 to 22.2) min reduction (p<0.005)). 98% people found the DVD length and information satisfactory. 85-89% felt it improved their understanding of risks/benefits/implications/purpose of genetic testing. 95% would recommend it to others. The cost of genetic counselling for DVD-C=£7787 and TC=£17 307. DVD-C resulted in cost savings=£9520 (£14/volunteer).

CONCLUSIONS:

DVD-C is an effective, acceptable, non-inferior, time-saving and cost-efficient alternative to TC.

TRIAL REGISTRATION NUMBER:

ISRCTN 73338115.

KEYWORDS:

BRCA1, BRCA2; Cluster Randomised trial; Genetic screening/counselling; Population based testing; genetic testing

PMID:
26993268
DOI:
10.1136/jmedgenet-2015-103740
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center